Research News

FDA Approves Cyclodextrin Clinical Trial

Cyclodextrin Drug Trial Update November 14, 2012 From Dr. Forbes Porter, Clinical Director of the Division of Intramural Research at the National Institute of Child Health and Human Development, National Institutes of Health in Bethesda, Maryland. The Therapies for Rare and Neglected Diseases (TRND) team is pleased to announce that the Investigational New Drug (IND) …